How cannabinoids control nausea and vomiting in the body

Both THC and CBD reduced nausea and vomiting in animal studies, with CBD working through serotonin receptors rather than the cannabinoid system.

Parker, Linda A et al.·British journal of pharmacology·2011·Moderate EvidenceReview
RTHC-00510ReviewModerate Evidence2011RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

This review pulled together decades of research on how the endocannabinoid system regulates nausea and vomiting. CB1 receptor activation consistently suppressed vomiting across multiple animal species, while CB1 inverse agonists (like rimonabant) actually promoted it.

CBD showed anti-nausea effects within a limited dose range, apparently working through serotonin 5-HT1A receptors in the brainstem rather than cannabinoid receptors directly. This is a different mechanism than THC uses.

Animal research suggested cannabinoids may be particularly effective against anticipatory nausea, the type that develops when patients begin to feel sick before chemotherapy even starts. This form of nausea responds poorly to standard anti-emetic drugs.

Key Numbers

CB1 agonists suppressed conditioned gaping (nausea proxy) in rats. CBD was effective within a limited dose range. FAAH inhibitor URB-597 also suppressed nausea responses.

How They Did This

This was a narrative review synthesizing preclinical and clinical evidence on cannabinoid regulation of nausea and vomiting. The authors examined studies across emetic species (ferrets, shrews) and rodent models using conditioned gaping reactions as a proxy for nausea.

Why This Research Matters

Standard anti-nausea medications work well for acute chemotherapy-induced vomiting but perform poorly against anticipatory nausea. This review identified cannabinoids as a potential tool for that gap, with CBD offering a non-intoxicating option.

The Bigger Picture

The distinction between THC and CBD mechanisms matters for drug development. CBD working through serotonin receptors means it could potentially be combined with existing anti-emetics that target different pathways, without the psychoactive effects of THC.

What This Study Doesn't Tell Us

Much of the evidence came from animal models. Rats and mice cannot vomit, so researchers used conditioned gaping as a proxy for nausea, which may not perfectly translate to human experience. Clinical trial data in humans was limited at the time of review.

Questions This Raises

  • ?What is the optimal CBD dose range for nausea in humans?
  • ?Can CBD be combined with standard anti-emetics for better results?
  • ?Why does CBD lose effectiveness outside its limited dose window?

Trust & Context

Key Stat:
CBD reduced nausea through serotonin receptors, not the cannabinoid system
Evidence Grade:
Narrative review synthesizing animal and limited clinical evidence. Provides mechanistic understanding but relies heavily on preclinical models.
Study Age:
Published in 2011. CBD anti-nausea research has expanded considerably since this review.
Original Title:
Regulation of nausea and vomiting by cannabinoids.
Published In:
British journal of pharmacology, 163(7), 1411-22 (2011)
Database ID:
RTHC-00510

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Does CBD work the same way as THC for nausea?

No. THC reduces nausea by activating CB1 cannabinoid receptors, while CBD appears to work through serotonin 5-HT1A receptors in the brainstem. These are completely different pathways.

What is anticipatory nausea?

Anticipatory nausea develops when patients begin feeling sick before a chemotherapy treatment, triggered by cues associated with previous sessions. Standard anti-nausea drugs perform poorly against it.

Read More on RethinkTHC

Cite This Study

RTHC-00510·https://rethinkthc.com/research/RTHC-00510

APA

Parker, Linda A; Rock, Erin M; Limebeer, Cheryl L. (2011). Regulation of nausea and vomiting by cannabinoids.. British journal of pharmacology, 163(7), 1411-22. https://doi.org/10.1111/j.1476-5381.2010.01176.x

MLA

Parker, Linda A, et al. "Regulation of nausea and vomiting by cannabinoids.." British journal of pharmacology, 2011. https://doi.org/10.1111/j.1476-5381.2010.01176.x

RethinkTHC

RethinkTHC Research Database. "Regulation of nausea and vomiting by cannabinoids." RTHC-00510. Retrieved from https://rethinkthc.com/research/parker-2011-regulation-of-nausea-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.